Reply To: The Possible Combined Action of Different Trigger Agents in Rosacea.

2. Bunyaratavej S, Rujitharanawong C, Kasemsarn P, Boonchai W, Muanprasert C, Matthapan L, et al. Skin scrapings versus standardized skin surface biopsy to detect Demodex mites in patients with facial erythema of uncertain cause -a comparative study. Indian J Dermatol Venereol Leprol. 2016;82:519--22, http://dx.doi.org/10.4103/0378-6323.174423 3. Blakley BR, Rousseaux CG. Effect of ivermectin on the immune response in mice. Am J Vet Res. 1991;52:593--5. 4. Schaller M, Gonser L, Belge K, Braunsdorf C, Nordin R, Scheu A, et al. Dual anti-inflammatory and antiparasitic action of topical ivermectin 1% in papulopustular rosacea. J Eur Acad Dermatol Venereol. 2017, http://dx.doi.org/10.1111/jdv.14437 5. Lacey N, Delaney S, Kavanagh K, Powell FC. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol. 2007;157:474--81. 6. Gallo R, Drago F, Paolino S, Parodi A. Rosacea treatments: what’s new and what’s on the horizon? Am J Clin Dermatol. 2010;11:299--303, http://dx.doi.org/10.2165/ 11537020-000000000-00000 7. Parodi A, Paolino S, Greco A, Drago F, Mansi C, Rebora A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008;6:759--64, http://dx.doi.org/10.1016/j.cgh.2008.02.054 8. Agnoletti AF, DE Col E, Parodi A, Schiavetti I, Savarino V, Rebora A, et al. Etiopathogenesis of rosacea: a prospective study with a three-year follow-up. G Ital Dermatol Venereol. 2016. 9. Drago F, De Col E, Agnoletti AF, Schiavetti I, Savarino V, Rebora A, et al. The role of small intestinal bacterial overgrowth in rosacea: a 3-year follow-up. J Am Acad Dermatol. 2016;75:e113--5, http://dx.doi.org/10.1016/j.jaad.2016.01.059